Evommune
EVMN
NYSE
IPO2025
about EVMN
Evommune is a clinical-stage biotechnology company developing innovative immuno-oncology treatments to address various forms of cancer.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $22.00 | $22.49 | $21.69 | $658.70M | 71.86K |